Huang Xuerui,Gao Weiwei,Bu Jianling,et al.. Analysis of therapeutic effect on the individualized regimens for 69 patients with multi-drug resistant pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2004, 26(5): 257-260.
1 中国防痨协会.结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28.
2 中华医学会结核病科学会.肺结核化学疗法[J].中华结核和呼吸系疾病杂志,1982,5(6):381-385.
3 Maranetra K N.Quinolones and of multidrug-resistant tuberculosis[J].Chemotherapy, 1999,45(S2):12-18.
4 Yew W W,Kwan S Y,Ma W K,et al.In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clipical efficacy in multi-drug-resistant tuberculosis [J].J Antimicrob Chemother, 1990,26:227-236.
5 蔡宝云,马玙,张金福,等.含安美汀方案治疗多耐药结核病的近期疗效初步观察[J].中国防痨杂志,2000,22(3):140-141.
6 Iwanaga T,Yokota K,Kishikawa,et al.The combination of amoxi-cillin-clavulanic acid and ofloxacin in the treatment of multidrug-re-sistant Mycobacterium tuberculosis [J]. Kekkaku, 1997,72(1):9.
7 Chambers H F,Kocagoz T,Sipit T,et al. Activity of amoxicillin/cla-vulanate in patients with tuberculosis [J]. Clin-Infect-Dis, 1998,26(4):874.
8 姚顺坤,何盛秋.结核菌初始菌耐药对肺结核短化的影响[J].中国防痨杂志,1995,17(1):15.